Table 2. Characteristics of patients (undergoing ICSI treatment) with low (<25th percentile), average (25th to 75th percentile) and high (>75th percentile) levels of serum AMH on day 3
Characteristics AMH (ng/ml)
<1.17 1.17-4.33 >4.33
N 55 110 53
Age (y) 36.07±3.37 36.81±4.4 36.38±4.65
Duration of infertility (y) 5.65±3.95 5.42±4.69 4.94±3.63
AFC 11.91±5.11 13.17±6.33 18.75±6.54ab,ac
BMI (kg/m2) 23.35±4.81 23.25±3.93 24.01±2.83
E2 (pg/ml) 70.99±65.19 98.33±196.34 168.03±692.18
FSH (ng/ml) 6.71±2.74 6.55±4.26 5.4±2.23
LH (ng/ml) 4.32±2.54 4.47±3.92 3.26±2.35
T (ng/ml) 0.34±0.22 1.14±3.75 0.57±0.26
Number of retrieved oocytes (n) 7.09±3.04 13.17±6.33 18.53±8.65ab,ac
FR (%) 73.87±21.01 73.03±18.08 66.59±16.37
GQEs (n) 2.72±1.6 4.03±3.46 4.9±4.31ab
CPR (%) 32(8/25) 34.55(19/55) 42.31(11/26)

Data expressed as mean ± standard deviation. Kruskal-Wallis test was used and a p value <0.05 was considered statistically significant.
AFC: antral follicle count; BMI: body mass index; E2: estradiol; FSH: follicle-stimulating hormone; LH: luteinizing hormone; T: testosterone; FR: fertilization rate; GQE: number of good quality embryos; CPR: clinical pregnancy rate.
aKruskal-Wallis multiple comparison test was used to determine which group differed from others.
b<.001, low versus high.
c<.001, average versus high.